Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017 (2017), Article ID 8415094, 11 pages
https://doi.org/10.1155/2017/8415094
Research Article

IL-10-Producing B Cells Suppress Effector T Cells Activation and Promote Regulatory T Cells in Crystalline Silica-Induced Inflammatory Response In Vitro

1Division of Pneumoconiosis, School of Public Health, China Medical University, Shenyang, China
2Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China

Correspondence should be addressed to Jie Chen

Received 13 February 2017; Accepted 11 June 2017; Published 2 August 2017

Academic Editor: Alex Kleinjan

Copyright © 2017 Yiping Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. R. Satpathy, V. R. Jala, S. R. Bodduluri et al., “Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth,” Nature Communications, vol. 6, p. 7064, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Lopes-Pacheco, E. Bandeira, and M. M. Morales, “Cell-based therapy for silicosis,” Stem Cells International, vol. 2016, Article ID 5091838, 9 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. H. L. Tan, M. Faisal, C. I. Soo, A. Y. Ban, R. A. Manap, and T. M. Hassan, “Dental technician pneumoconiosis mimicking pulmonary tuberculosis: a case report,” BMC Pulmonary Medicine, vol. 16, p. 131, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. J. W. Lee, J. P. Myong, Y. J. Choi, S. Lee, B. S. Jo, and J. W. Koo, “Diagnosis of perinuclear anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis in silicotics: case report,” Annals of Occupational and Environmental Medicine, vol. 28, p. 21, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Huaux, “New developments in the understanding of immunology in silicosis,” Current Opinion in Allergy and Clinical Immunology, vol. 7, no. 2, pp. 168–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Takato, M. Yasui, Y. Ichikawa et al., “The specific chymase inhibitor TY-51469 suppresses the accumulation of neutrophils in the lung and reduces silica-induced pulmonary fibrosis in mice,” Experimental Lung Research, vol. 37, pp. 101–108, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. C. C. Leung, I. T. S. Yu, and W. Chen, “Silicosis,” The Lancet, vol. 379, pp. 2008–2018, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. K. M. Pollard, “Silica, silicosis, and autoimmunity,” Frontiers in Immunology, vol. 7, p. 97, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Chen, J. Yuan, S. Yao et al., “Lipopolysaccharides may aggravate apoptosis through accumulation of autophagosomes in alveolar macrophages of human silicosis,” Autophagy, vol. 11, pp. 2346–2357, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. F. E. Lund and T. D. Randall, “Effector and regulatory B cells: modulators of CD4+ T cell immunity,” Nature Reviews Immunology, vol. 10, pp. 236–247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Fillatreau, C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton, “B cells regulate autoimmunity by provision of IL-10,” Nature Immunology, vol. 3, pp. 944–950, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Han, L. Sun, X. Fan et al., “Role of regulatory b cells in neuroimmunologic disorders,” Journal of Neuroscience Research, vol. 94, pp. 693–701, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. D. G. Adlowitz, J. Barnard, J. N. Biear et al., “Expansion of activated peripheral blood memory B cells in rheumatoid arthritis, impact of B cell depletion therapy, and biomarkers of response,” PLoS One, vol. 10, article e0128269, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Li, A. Rezk, Y. Miyazaki et al., “Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy,” Science Translational Medicine, vol. 7, no. 310, article 310ra166, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Moreno Torres and A. Garcia-Merino, “Anti-CD20 monoclonal antibodies in multiple sclerosis,” Expert Review of Neurotherapeutics, vol. 17, no. 4, pp. 359–371, 2017. View at Publisher · View at Google Scholar
  16. X. Pan, Z. Ji, and J. Xue, “Percentage of peripheral CD19+CD24hiCD38hi regulatory B cells in neonatal sepsis patients and its functional implication,” Medical Science Monitor, vol. 22, pp. 2374–2378, 2016. View at Google Scholar
  17. F. Figueiró, L. Muller, S. Funk, E. K. Jackson, A. M. O. Battastini, and T. L. Whiteside, “Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg),” OncoImmunology, vol. 5, article e1082703, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Iwata, T. Matsushita, M. Horikawa et al., “Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells,” Blood, vol. 117, pp. 530–541, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. J. D. Bouaziz, H. Le Buanec, A. Saussine, A. Bensussan, and M. Bagot, “IL-10 producing regulatory B cells in mice and humans: state of the art,” Current Molecular Medicine, vol. 12, pp. 519–527, 2012. View at Google Scholar
  20. T. F. Tedder, “B10 cells: a functionally defined regulatory B cell subset,” The Journal of Immunology, vol. 194, pp. 1395–1401, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. E. C. Rosser and C. Mauri, “Regulatory B cells: origin, phenotype, and function,” Immunity, vol. 42, pp. 607–612, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. A. R. Khan, E. Hams, A. Floudas, T. Sparwasser, C. T. Weaver, and P. G. Fallon, “PD-L1hi B cells are critical regulators of humoral immunity,” Nature Communications, vol. 6, p. 5997, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Durand and E. Chiffoleau, “B cells with regulatory properties in transplantation tolerance,” World Journal of Transplantation, vol. 5, pp. 196–208, 2015. View at Publisher · View at Google Scholar
  24. X. Zhou, Y. X. Su, X. M. Lao, Y. J. Liang, and G. Q. Liao, “CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells,” Oral Oncology, vol. 53, pp. 27–35, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Chen, C. Li, D. Weng et al., “Neutralization of interleukin-17A delays progression of silica-induced lung inflammation and fibrosis in C57BL/6 mice,” Toxicology and Applied Pharmacology, vol. 275, pp. 62–72, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Song, D. Weng, W. Dai et al., “Th17 can regulate silica-induced lung inflammation through an IL-1beta-dependent mechanism,” Journal of Cellular and Molecular Medicine, vol. 18, pp. 1773–1784, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Tang, F. Liu, Y. Chen et al., “Reduction of IL-17A might suppress the Th1 response and promote the Th2 response by boosting the function of Treg cells during silica-induced inflammatory response in vitro,” Mediators of Inflammation, vol. 2014, Article ID 570894, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Liu, J. Liu, D. Weng et al., “CD4+CD25+Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice,” PLoS One, vol. 5, article e15404, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Song, D. Weng, F. Liu et al., “Tregs promote the differentiation of Th17 cells in silica-induced lung fibrosis in mice,” PloS One, vol. 7, article e37286, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Hayashi, Y. Miura, M. Maeda et al., “Reductive alteration of the regulatory function of the CD4(+)CD25(+) T cell fraction in silicosis patients,” International Journal of Immunopathology and Pharmacology, vol. 23, no. 4, pp. 1099–1109, 2010. View at Publisher · View at Google Scholar
  31. F. Liu, W. Dai, C. Li et al., “Role of IL-10-producing regulatory B cells in modulating T-helper cell immune responses during silica-induced lung inflammation and fibrosis,” Scientific Reports, vol. 6, article 28911, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Matsushita, M. Horikawa, Y. Iwata, and T. F. Tedder, “Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis,” Journal of Immunology, vol. 185, pp. 2240–2252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. K. M. Haas, S. Sen, I. G. Sanford, A. S. Miller, J. C. Poe, and T. F. Tedder, “CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo,” The Journal of Immunology, vol. 177, pp. 3063–3073, 2006. View at Google Scholar
  34. L. Zhou, M. M. Chong, and D. R. Littman, “Plasticity of CD4+ T cell lineage differentiation,” Immunity, vol. 30, pp. 646–655, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. D. S. Robinson and A. O'Garra, “Further checkpoints in Th1 development,” Immunity, vol. 16, pp. 755–758, 2002. View at Google Scholar
  36. J. Zhu, H. Yamane, J. Cote-Sierra, L. Guo, and W. E. Paul, “GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors,” Cell Research, vol. 16, pp. 3–10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Flores-Borja, A. Bosma, D. Ng et al., “CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation,” Science Translational Medicine, vol. 5, no. 173, article 173ra23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Kessel, T. Haj, R. Peri et al., “Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells,” Autoimmunity Reviews, vol. 11, pp. 670–677, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. M. M. Ansary, S. Ishihara, A. Oka et al., “Apoptotic cells ameliorate chronic intestinal inflammation by enhancing regulatory B-cell function,” Inflammatory Bowel Diseases, vol. 20, pp. 2308–2320, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Ray, S. Basu, C. B. Williams, N. H. Salzman, and B. N. Dittel, “A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand,” The Journal of Immunology, vol. 188, pp. 3188–3198, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Mauri and A. Bosma, “Immune regulatory function of B cells,” Annual Review of Immunology, vol. 30, pp. 221–241, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. T. F. Tedder and W. J. Leonard, “Autoimmunity: regulatory B cells—IL-35 and IL-21 regulate the regulators,” Nature Reviews Rheumatology, vol. 10, pp. 452-453, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. P. J. Rauch, A. Chudnovskiy, C. S. Robbins et al., “Innate response activator B cells protect against microbial sepsis,” Science, vol. 335, no. 6068, pp. 597–601, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. V. D. Dang, E. Hilgenberg, S. Ries, P. Shen, and S. Fillatreau, “From the regulatory functions of B cells to the identification of cytokine-producing plasma cell subsets,” Current Opinion in Immunology, vol. 28, pp. 77–83, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Yanaba, J. D. Bouaziz, T. Matsushita, T. Tsubata, and T. F. Tedder, “The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals,” Journal of Immunology, vol. 182, pp. 7459–7472, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Maseda, K. M. Candando, S. H. Smith et al., “Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-gamma+CD4+ T cell numbers during colitis development in mice,” Journal of Immunology, vol. 191, pp. 2780–2795, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Liu, L. Cheng, S. Wu et al., “IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection,” Clinical Science, vol. 130, pp. 907–919, 2016. View at Publisher · View at Google Scholar
  48. M. Sayan and B. T. Mossman, “The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases,” Particle and Fibre Toxicology, vol. 13, p. 51, 2016. View at Publisher · View at Google Scholar · View at Scopus
  49. S. E. Mischler, E. G. Cauda, M. Di Giuseppe et al., “Differential activation of RAW 264.7 macrophages by size-segregated crystalline silica,” Journal of Occupational Medicine and Toxicology, vol. 11, p. 57, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Abramson and E. S. Husebye, “Autoimmune regulator and self-tolerance—molecular and clinical aspects,” Immunological Reviews, vol. 271, no. 1, pp. 127–140, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. M. O. Li and A. Y. Rudensky, “T cell receptor signalling in the control of regulatory T cell differentiation and function,” Nature Reviews Immunology, vol. 16, pp. 220–233, 2016. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Tanaka and S. Sakaguchi, “Regulatory T cells in cancer immunotherapy,” Cell Research, vol. 27, pp. 109–118, 2016. View at Google Scholar
  53. L. H. Hsu, K. P. Li, K. H. Chu, and B. L. Chiang, “A B-1a cell subset induces Foxp3(−) T cells with regulatory activity through an IL-10-independent pathway,” Cellular & Molecular Immunology, vol. 12, pp. 354–365, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Noh and J. H. Lee, “Regulatory B cells and allergic diseases,” Allergy, Asthma & Immunology Research, vol. 3, pp. 168–177, 2011. View at Google Scholar
  55. T. Adjobimey, J. Satoguina, J. Oldenburg, A. Hoerauf, and L. E. Layland, “Co-activation through TLR4 and TLR9 but not TLR2 skews Treg-mediated modulation of Igs and induces IL-17 secretion in Treg: B cell co-cultures,” Innate Immunity, vol. 20, pp. 12–23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. F. T. Lu, W. Yang, Y. H. Wang et al., “Thymic B cells promote thymus-derived regulatory T cell development and proliferation,” Journal of Autoimmunity, vol. 61, pp. 62–72, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. P. A. Blair, L. Y. Norena, F. Flores-Borja et al., “CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients,” Immunity, vol. 32, pp. 129–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Das, G. Ellis, C. Pallant et al., “IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection,” The Journal of Immunology, vol. 189, pp. 3925–3935, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Rincon-Arevalo, C. C. Sanchez-Parra, D. Castano, L. Yassin, and G. Vasquez, “Regulatory B cells and mechanisms,” International Reviews of Immunology, vol. 35, pp. 156–176, 2016. View at Google Scholar